ASCENDIA
Dead / Cancelled — Cancelled — Section 18 (TTAB) (as of 20 Jun 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97021166
- Registration number
- 6859058
- Mark type
- Stylized text
- Filed
- 10 Sept 2021
- Published for opposition
- 12 Jul 2022
- Registered
- 27 Sept 2022
Goods and services
- Class 042 — Scientific and technological services: research and development of pharmaceuticals designed via physical means to be released into the body over a period of time
Owner
- Ascendia Pharmaceuticals, Inc., North Brunswick, NJ, US
- Ascendia Pharmaceuticals, Inc., North Brunswick, NJ, US
- Ascendia Pharmaceuticals, Inc., North Brunswick, NJ, US
Prosecution history
- 20 Jun 2024 — CANCELLED SECTION 18-TOTAL
- 20 Jun 2024 — CANCELLATION TERMINATED NO. 999999
- 20 Jun 2024 — CANCELLATION GRANTED NO. 999999
- 03 Apr 2023 — CANCELLATION INSTITUTED NO. 999999
- 27 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 12 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Jul 2022 — PUBLISHED FOR OPPOSITION
- 22 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Jun 2022 — ASSIGNED TO EXAMINER
- 19 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Sept 2021 — NEW APPLICATION ENTERED